Upgrade to SI Premium - Free Trial

Clearmind Medicine gets safety board approval to continue alcohol disorder trial

April 15, 2026 7:31 AM
Clearmind Medicine Inc. (NASDAQ: CMND) received a positive recommendation from its independent Data and Safety Monitoring Board to continue its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA